Table 3 Blood chemistry and plasma oxidative stress levels
From: Rho kinase cascade activation in circulating leukocytes in patients with diabetes mellitus type 2
Control subjects (n = 31) | T2D patients (n = 28) | p | |
|---|---|---|---|
Hematocrit (%) | 42.9 ± 3.4 | 40.8 ± 3.4 | 0.020 |
Hemoglobin (mmol/L) | 14.5 ± 1.4 | 13.8 ± 1.3 | 0.040 |
WBC/Ml | 6003.2 ± 1461.4 | 7465.9 ± 1733.8 | 0.020 |
Plasma creatinine (mEq/L) | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.690 |
ESR | 6.5 ± 5.9 | 13.0 ± 15.9 | 0.030 |
BUN (mg/L) | 13.2 ± 4.8 | 16.7 ± 4.1 | 0.030 |
Potassium, serum (mEq/L) | 4.3 ± 0.7 | 4.3 ± 0.4 | 0.680 |
Glucose, serum (mg/dL) | 89.2 ± 6.71 | 155.0 ± 59.2 | 0.001 |
Uric acid (μmol/L) | 5.1 ± 1.2 | 4.4 ± 1.4 | 0.040 |
BUN/plasma creatinine | 17.7 ± 3.4 | 22.2 ± 5.7 | 0.010 |
Serum Cholesterol (mg/dL) | 204.5 ± 22.5 | 160.1 ± 42.3 | 0.001 |
LDL Cholesterol (mg/dL) | 124.4 ± 23.9 | 87.2 ± 34.7 | 0.001 |
HDL Cholesterol (mg/dL) | 55.7 ± 14.3 | 44.1 ± 9.4 | 0.001 |
Triglicerydes (mg/dL) | 127.0 ± 63.3 | 144.1 ± 72.9 | 0.340 |
SGOT (U/L) | 21.2 ± 6.3 | 19.7 ± 6.1 | 0.350 |
MAU (ug/mL) | 2.2 ± 3.0 | 23.6 ± 40.77 | 0.010 |
MAU/urine creatinine ratio (mg/g creat) | 4.9 ± 1.8 | 28.3 ± 50.6 | 0.030 |
MDA (uM) | 1.1 ± 0.4 | 1.8 ± 1.1 | 0.010 |